|
|
||||||||
From Alcon Research, Ltd., Fort Worth, Texas.
PURPOSE. Matrix metalloproteinases (MMPs) are involved in trabecular meshwork (TM) extracellular matrix metabolism and have been shown to increase aqueous outflow facility. The purpose of this study was to characterize effects of cytokines, a phorbol ester, and prostanoids on the expression of MMP-1, -2, -3, and -9 and tissue inhibitors of metalloproteinases (TIMP)-1 and -2 in cultured human TM cells.
METHODS. Five human TM cell strains were treated with selected compounds. Levels of proMMPs and TIMPs in cell media were quantified by ELISA. MMP-3 activity was assayed by casein zymography.
RESULTS. All human TM cell strains produced detectable basal amounts of proMMPs and TIMPs. 12-O-tetradecanoyl-phorbol-13-acetate was effective in increasing the levels of proMMP-1, -3, and -9 and TIMP-1. Its effect on proMMP-1 was concentration-dependent with an EC50 of 2 to 3 nM. Interleukin (IL)-1
did not affect levels of proMMP-1 and -2 or the TIMPs, but was most efficacious in increasing proMMP-3 production with an EC50 of 0.5 ng/mL. The IL-1
induced upregulation of proMMP-3 correlated with an increase in MMP-3 activity. Tumor necrosis factor-
activated proMMP-3 production in some but not all cell strains. Platelet-derived growth factor-BB was generally ineffective in modulating MMP and TIMP levels. Prostaglandins E2 and F2
at 10 µM did not affect levels of proMMP-1 or -3.
CONCLUSIONS. The expression of the different MMPs and TIMPs in human TM cells was independently regulated. Production of MMP-3 was maximally activated by IL-1
. The IL-1
stimulated expression of MMP-3 provides a probable mechanism for IL-1
enhanced aqueous outflow.
This article has been cited by other articles:
![]() |
T. Tovar-Vidales, R. Roque, A. F. Clark, and R. J. Wordinger Tissue Transglutaminase Expression and Activity in Normal and Glaucomatous Human Trabecular Meshwork Cells and Tissues Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 622 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Kelley, A. Y. Rose, K. Song, Y. Chen, J. M. Bradley, D. Rookhuizen, and T. S. Acott Synergism of TNF and IL-1 in the Induction of Matrix Metalloproteinase-3 in Trabecular Meshwork Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2634 - 2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. S. How, T. Aung, X. Chew, V. H. K. Yong, M. C. C. Lim, K. Y. C. Lee, J.-Y. Toh, Y. Li, J. Liu, and E. N. Vithana Lack of Association between Interleukin-1 Gene Cluster Polymorphisms and Glaucoma in Chinese Subjects Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2123 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Oh, J. L. Martin, A. J. Williams, P. Russell, D. E. Birk, and D. J. Rhee Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3887 - 3895. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Fautsch, K. G. Howell, A. M. Vrabel, M. C. Charlesworth, D. C. Muddiman, and D. H. Johnson Primary Trabecular Meshwork Cells Incubated in Human Aqueous Humor Differ from Cells Incubated in Serum Supplements Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2848 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
S L Ho, G F Dogar, J Wang, J Crean, Q D Wu, N Oliver, S Weitz, A Murray, P E Cleary, and C O'Brien Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome Br. J. Ophthalmol., February 1, 2005; 89(2): 169 - 173. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Mettu, P.-F. Deng, U. K. Misra, G. Gawdi, D. L. Epstein, and P. V. Rao Role of Lysophospholipid Growth Factors in the Modulation of Aqueous Humor Outflow Facility Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2263 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Fleenor, I.-H. Pang, and A. F. Clark Involvement of AP-1 in Interleukin-1{alpha}-Stimulated MMP-3 Expression in Human Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3494 - 3501. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-H. Pang, D. L. Fleenor, P. E. Hellberg, K. Stropki, M. D. McCartney, and A. F. Clark Aqueous Outflow-Enhancing Effect of tert-Butylhydroquinone: Involvement of AP-1 Activation and MMP-3 Expression Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3502 - 3510. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |